Registry of stroke cases in Brest
The Brest Registry of Stroke
This study is collecting information on stroke cases in Brest to see how common strokes are, understand their impact on patients, and find better ways to treat them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 15000 (estimated) |
| Ages | 15 Years and up |
| Sex | All |
| Sponsor | University Hospital, Brest Academic / other |
| Locations | 1 site (Brest) |
| Trial ID | NCT02900521 on ClinicalTrials.gov |
What this trial studies
The Brest Stroke Registry aims to compile all confirmed stroke cases within a specific geographical area to calculate the incidence of strokes. This observational study will gather data on both ischemic and hemorrhagic strokes, focusing on mortality rates in the short and long term. Additionally, it will assess current clinical practices and propose optimal management strategies for stroke patients, aligning with public health initiatives to improve healthcare quality and safety. The registry will also analyze the bleeding risks associated with anticoagulants and anti-platelet agents.
Who should consider this trial
Good fit: Ideal candidates include individuals aged over 15 who have been diagnosed with ischemic stroke, non-traumatic intracranial hematoma, or cerebral venous thrombosis after December 31, 2007, and reside in the defined geographical area.
Not a fit: Patients under 15 years old or those with unconfirmed diagnoses or specific conditions like aneurysmal subarachnoid hemorrhage will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of stroke incidence and mortality, leading to improved management and treatment strategies for stroke patients.
How similar studies have performed: Other similar registries have shown success in improving stroke management and understanding epidemiological trends, indicating that this approach is both tested and valuable.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnostic validated for one of the following pathologies: * Ischemic stroke, * Non-traumatic intracranial hematoma * Cerebral venous thrombosis Diagnostic after December 31, 2007 Age \> 15 years on the date of the diagnostic Patient domiciled at the time of the diagnostic in one of the 79 communes defined beforehand Exclusion Criteria: * Age ≤ 15 years * Validated diagnosis (see below, § 4.2.2) of aneurysmal subarachnoid hemorrhage cerebrovascular * Diagnosis made before 1 January 2008 * Unconfirmed diagnosis * Patient domiciled outside the previously defined area of residence
Where this trial is running
Brest
- CHRU de Brest — Brest, France (Recruiting)
Study contacts
- Principal investigator: Serge TIMSIT — CHRU La Cavale Blanche - BREST - FRANCE
- Study coordinator: Serge TIMSIT
- Email: serge.timsit@chu-brest.fr
- Phone: +33298347620
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.